Skip to main content
Smart Investors Daily
NL

NYSE · NLS

Nautilus, Inc.

Consumer Cyclical · Leisure

$0.82

Up+$0.08 (+11.20%)

Updated Oct 8, 2026, 4:10 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
29.61M
P/E ratio
-0
Dividend yield
0.00%
52-week range
— – —
Volume
269.69K
Avg. volume
206.8K

Price performance · NLS

NLS price history

1M range · 0 trading sessions · Daily adjusted prices

NLS does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest NLS news

The latest Smart Investors Daily articles mentioning NLS.

NLS research

Overview

Company profile and research snapshot.

Company profile

Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer and commercial use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates in two segments, Direct and Retail. It offers specialized cardio products, treadmills, ellipticals, bike products, home gyms, dumbbells, barbells, and kettlebells primarily under the Nautilus, Bowflex, Octane Fitness, and Schwinn brands, as well as fitness digital platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
NLS recent ratings
DateFirmRatingTarget
Feb 10, 2023William BlairMarket Perform—
Oct 5, 2022Truist SecuritiesBuy—
May 24, 2022Lake StreetBuy—
May 24, 2022Truist SecuritiesBuy—
May 24, 2022Craig-HallumHold—
Open full forecast

News briefing

No generated briefing is available yet.

globenewswire.com · Nov 3, 2025

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

• Buck Institute's deployment of Nautilus' instrument generates tau proteoform data, providing external validation of the company's next-generation single-molecule proteomics platform  • Joint research results show high reproducibility across sites and insight into novel tau biology, signaling a fundamental shift in how proteomics technology can advance human health and longevity • Data presentation at the 2025 HUPO World Congress seminar “Redefining Proteomics with Single-Molecule Iterative Mapping” on November 10

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.